ReviewThe Australasian journal of dermatology2020

COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.

Charlie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.